British researchers have unveiled a second-generation CAR-T therapy, reporting promising findings in an early trial involving patients with treatment resistant B-cell acute lymphoblastic leukaemia.
Researchers at University College London develope...
1 month ago
A new JAK inhibitor drug may help reduce the risk of graft versus host disease in half-matched stem cell transplants, according to a new study.
A phase I trial of the investigational drug, itacitinib, has had unexpectedly promising results, accord...
1 month ago